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The protein kinase Bb (Akt2) pathway is known
to mediate insulin-stimulated glucose transport
through increasing glucose transporter GLUT4 trans-
location from intracellular stores to the plasma
membrane (PM). Combining quantitative phospho-
proteomics with RNAi-based functional analyses,
we show that a previously uncharacterized 138 kDa
C2 domain-containing phosphoprotein (CDP138) is
a substrate for Akt2, and is required for optimal
insulin-stimulated glucose transport, GLUT4 translo-
cation, and fusion of GLUT4 vesicles with the PM in
live adipocytes. The purified C2 domain is capable
of binding Ca2+ and lipid membranes. CDP138
mutants lacking the Ca2+-binding sites in the C2
domain or Akt2 phosphorylation site S197 inhibit
insulin-stimulated GLUT4 insertion into the PM,
a rate-limiting step of GLUT4 translocation. Interest-
ingly, CDP138 is dynamically associated with the PM
andGLUT4-containing vesicles in response to insulin
stimulation. Together, these results suggest that
CDP138 is a key molecule linking the Akt2 pathway
to the regulation of GLUT4 vesicle-PM fusion.
INTRODUCTION
Insulin regulates glucose transport into skeletal muscle and
adipose tissue by increasing the cell surface localization of the
glucose transporter GLUT4 (Bryant et al., 2002; Huang and
Czech, 2007). In the basal state, GLUT4 is retained within
specific intracellular compartments, and insulin rapidly increases
the movement of GLUT4 from its intracellular compartment to
the plasma membrane (PM), where it captures the extracellular
glucose for internalization. This effect is essential to maintain
glucose homeostasis in humans, and impaired insulin action378 Cell Metabolism 14, 378–389, September 7, 2011 ª2011 Elseviecontributes to the development of type II diabetes (Saltiel and
Kahn, 2001).
Insulin binding to its tyrosine kinase receptor results in tyrosine
phosphorylation of insulin receptor substrate (IRS) proteins (Sun
et al., 1991). Phosphorylated IRS proteins bind to and activate
phosphoinositide 3-kinase (PI3K), which phosphorylates poly-
phosphoinositides to form PI(3,4)P2, and PI(3,4,5)P3 (Cantley,
2002). The latter recruits the protein kinase B (Akt) and the phos-
phoinositide-dependent kinase (PDK-1) to the PM, where PDK-1
(Alessi et al., 1997) and the mTORC2 complex phosphorylate
and activate Akt (Sarbassov et al., 2005). Several lines of
evidence strongly suggest that activation of the PI3K-Akt2
pathway is necessary for insulin to induce GLUT4 translocation
and for glucose transport (Martin et al., 1996). First, PI(3,4,5)P3
formation is required for GLUT4 insertion into the PM (Tengholm
and Meyer, 2002). Second, expression of constitutively active
Akt in adipocytes increases glucose uptake (Kohn et al., 1996),
and conversely, a dominant negative form of Akt inhibits
insulin-induced GLUT4 translocation (Hill et al., 1999; Wang
et al., 1999). Third, siRNA-mediated knockdown of Akt, particu-
larly Akt2, significantly reduces insulin-stimulated glucose trans-
port and GLUT4 translocation in cultured cells (Jiang et al.,
2003). Fourth, a diabetes-like phenotype is observed in Akt2
knockout mice (Cho et al., 2001), and fifth, an inactivating muta-
tion in Akt2 in humans leads to the development of severe insulin
resistance and diabetes mellitus (George et al., 2004).
The GLUT4 exocytic pathway includes glucose storage
vesicle (GSV) sorting, trafficking, docking, tethering, and finally,
fusion with the PM (Thurmond and Pessin, 2001). Accumulated
evidence suggests that activation of Akt2 is involved in regu-
lating both mobilization GSV to the periphery and membrane
fusion between GSV and the PM, and that this may occur
through phosphorylation of different substrates. Akt has been
shown to regulate GSV trafficking to and docking at the PM
(Gonzalez and McGraw, 2006). This is consistent with the
observation that Akt2 is recruited to and phosphorylates GSV
components (Calera et al., 1998; Kupriyanova and Kandror,
1999). There is compelling evidence suggesting that Akt2 is
also required for GSV-PM fusion (Chen et al., 2003; Koumanovr Inc.
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studies showed that Akt phosphorylation of AS160 stimulates
GLUT4 trafficking (Eguez et al., 2005; Sano et al., 2003), but
not the GSV-PM fusion step in cultured adipocytes (Bai et al.,
2007; Jiang et al., 2008), suggesting that other Akt2 substrate(s)
might be required for the last step of GLUT4 translocation.
In this study, we used quantitative phosphoproteomics and
RNAi-based functional analyses to identify a previously unchar-
acterized 138 kDa C2 domain-containing phosphoprotein
(CDP138) that is required for optimal GSV-PM fusion during
GLUT4 translocation and for subsequent maximal insulin-stimu-
lated glucose transport. Our data show that CDP138 functions
downstream of Akt2 and dynamically associates with both the
PM and GLUT4 vesicles. In addition, the C2 domain binds
Ca2+ and membrane lipids. Both the intact C2 domain and the
Akt2 phosphorylation site of CDP138 are necessary for full
insulin-stimulated GLUT4 translocation. These observations
establish CDP138 as amolecular link between insulin-stimulated
Akt2 signaling and GLUT4 insertion into the PM.
RESULTS
Identification of CDP138 as an Akt2 Substrate Using
SILAC-Based Quantitative Proteomics
A mass spectrometry (MS)-based approach, termed stable
isotope labeling with amino acids in cell culture (SILAC), has
provided a highly sensitive tool to identify and quantify phos-
phorylated proteins in cultured cells (Kru¨ger et al., 2008; Olsen
et al., 2006). To identify potential new Akt substrates in insulin-
stimulated adipocytes, three parallel cultures of 3T3-L1 preadi-
pocytes were metabolically labeled with different SILAC amino
acids to make their proteomes distinguishable, before differenti-
ated adipocytes were treated with or without the PI3K inhibitor
wortmannin followed by insulin as outlined in Figure 1A. Equal
amounts of total cell lysate from the three different samples
were pooled and subjected to immunoprecipitation to enrich
for phosphorylated Akt substrates (PAS) using antibodies (Abs)
against the PAS motif RXRXXS/T (Alessi et al., 1996; Obata
et al., 2000). The tryptic peptides were subsequently analyzed
by tandem MS. Using this approach, we identified 128 proteins,
including 21 known Akt substrates enriched more than 1.5-fold
from insulin-treated cells (Table S1). Among them, the pre-
viously uncharacterized CDP138, encoded by 5730419I09Rik
(kiaa0528), was enriched from insulin-stimulated cells but was
significantly inhibited in the cells pretreated with wortmannin
(Figure 1A and Table S1). CDP138 contains a predicted C2
domain similar to those present in the Ca2+ receptor synaptotag-
mins, known to be required for vesicle exocytosis (Bai and
Chapman, 2004).
We constructed a cDNA clone (IMAGE: 40125694,
GI:109658767) encoding the full-length human KIAA0528 protein
taggedwith three N-terminal HA epitopes. As shown in Figure 1B
(left panel), insulin stimulates phosphorylation of HA-tagged
CDP138 in CHO-T cells, as detected with PAS Abs. Insulin-stim-
ulated phosphorylation was significantly inhibited by wortman-
nin. An Ab to a peptide from CDP138 was used to analyze
endogenous protein in 3T3-L1 adipocytes by immunoprecipita-
tion and immunoblotting (Figure 1B, right panel). CDP138 from
insulin-treated cells migrated more slowly in SDS-PAGE thanCell MeCDP138 from control cells, and the apparent size shift was
reversed by LY294002, a PI3K inhibitor. This pattern of migration
is consistent with CDP138 being phosphorylated in insulin-stim-
ulated cells. CDP138 phosphorylation, as detected with PAS
Abs, reaches a maximum at 10 min and is sustained after
30min upon insulin stimulation (Figure S1). We detectedmultiple
phosphorylation sites in CDP138 by MS measurements (Fig-
ure 1A). To determine if Akt2 can directly phosphorylate
CDP138, HA-CDP138 was expressed in HEK293 cells and
immunoprecipitated with anti-HA Ab before being subjected to
an in vitro kinase assay in the presence of constitutively active
myristoylated Akt2 (myr-HA-Akt2) and g-32P-ATP. Figure 1C
shows that active Akt2 does induce CDP138 phosphorylation,
demonstrating that CDP138 is an Akt2 substrate. MS analysis
of an HA-CDP138 sample from the in vitro kinase assay revealed
that active Akt2 induces CDP138 phosphorylation at S197,
which lies within a consensus Akt substrate motif RQRLIS197
(Figure 1C). Conversion of S197 to alanine blocked active
Akt2-induced CDP138 phosphorylation detected with PAS
Abs, further confirming S197 is the Akt2 phosphorylation site.
CDP138 protein is expressed in all tissues tested including
insulin-sensitive tissues such as liver, muscle, and fat (Figure 1D,
left panel). Interestingly, as shown in Figure 1D (middle and right
panels), the CDP138 protein level, similar to that of IRS1, is
significantly reduced in fat tissue from insulin-resistant ob/ob
mice, suggesting that CDP138 is a highly regulated protein in
insulin-sensitive tissues.
CDP138 Is Required for Maximal Insulin-Stimulated
Glucose Transport and GLUT4 Translocation but Not
Endocytosis
Since activation of the Akt2 pathway is important for insulin-stim-
ulated glucose transport and C2 domain-containing proteins
such as synaptotagmins are known to be involved in membrane
trafficking, we next determined whether loss of CDP138 affects
insulin-stimulated glucose transport in adipocytes. As shown in
Figure 2A (upper panel), siRNA-induced silencing of CDP138
in 3T3-L1 adipocytes reduced protein levels by about 80%
without significant effects on insulin-induced Akt phosphoryla-
tion or other protein expression, as compared with cells trans-
fected with scrambled siRNA. The reduction in CDP138 protein
levels was accompanied by a decrease in insulin-induced
glucose transport by about 40%–45% (Figure 2A, lower panel),
suggesting that CDP138 is required for glucose transport. To
determine whether the reduced glucose transport was due to
an effect on the GLUT4 exocytic pathway, we performed
GLUT4 translocation assays in 3T3-L1 adipocytes transfected
with CDP138 siRNA or the scrambled siRNA, together with the
DNA construct encoding a myc-GLUT4-GFP fusion protein
with a myc epitope inserted in the first exofacial loop and GFP
at the C terminus of GLUT4 (Figure 2B) (Jiang et al., 2002).
GLUT4 translocation is quantified by measuring the ratio of cell
surface myc signal detected by anti-myc immunofluorescent
staining to the total GFP intensity as the myc-GLUT4-GFP
expression level in nonpermeabilized cells. At low concentra-
tions (1 nM), insulin caused a 3-fold increase in GLUT4 transloca-
tion (Figure 2B), and CDP138 gene-specific silencing resulted
in a 43% decrease in insulin-stimulated GLUT4 translocation.
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Figure 1. An Uncharacterized C2Domain-Containing Protein Encoded by 5730419I09Rik Is a Phosphoprotein Identified in Insulin-Stimulated
Adipocytes Using a SILAC Phosphoproteomic Approach
(A) Schematic procedure for SILAC quantitative proteomics used for identification and quantification of peptide from CDP138 (5730419I09Rik). Quantification
of CDP138 peptide from different groups of adipocytes (top right panel). Schematic diagram of CDP138 and the identified phosphorylation sites (lower right
panel).
(B) Confirmation of CDP138 phosphorylation induced by insulin. CHO-T cells expressing HA-CDP138 or differentiated 3T3-L1 adipocytes were treated with or
without insulin (100 nM) for 15 min. A third sample was pretreated with wortmannin (100 nM, WM) for 20 min or LY294002 (50 mM, LY) for 1 hr before insulin
stimulation. Left panel: HA-CDP138 was immunoprecipitatedwith anti-HA Ab fromCHO-T cells and blotted first with the phospho-Akt substrate PAS pAb (#9611,
Lot 2, Cell Signaling), and then reblotted with an anti-HA Ab. An anti-CDP138 peptide Ab was used for immunoprecipitation of CDP138 from cell lysates of
adipocytes followed by immunoblotting with the same Ab (right panel). CDP138, pS473-Akt, and Akt protein were also detected with total cell lysates. The arrows
indicate the insulin-stimulated CDP138 mobility shift.
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Figure 2. Knockdown of CDP138 in 3T3-L1 Adipocytes Inhibits Insulin-Stimulated Glucose Transport and myc-GLUT4-GFP Translocation,
but Not Endogenous GLUT4 Movement to the Periphery Detected in TIRF Zone
(A) Differentiated adipocytes at day five were transfected with siRNAs against mouse 5730419I09Rik or the scrambled siRNA (Scr) as described earlier (Jiang
et al., 2003) for 60 hr, then serum-starved overnight. Cells were then treated with or without insulin (1 nM and 100 nM) for 30 min for the glucose uptake assay, or
15 min for immunoblotting of CDP138, pAkt, Akt, and b-actin. Glucose transport data are presented as mean ± SD of four independent experiments. *p < 0.05
versus Scr Insulin (1nM) group; **p < 0.01 versus Scr Insulin (100 nM) group.
(B) Day five adipocyteswere transfectedwith siRNAs andmyc-GLUT4-GFP for 60 hr and then serum-starved overnight. Cells were then treatedwith insulin (1 nM)
for 20 min. Cell surface myc-GLUT4-GFP was detected with anti-myc monoclonal Ab (9E10) and Alexa Fluor 568-labeled goat anti-mouse IgG in non-
permeabilized cells. The myc signal and GFP signal were quantified as previously described (Jiang et al., 2002). Data presented are representative microscopic
images and mean ± SD of about 160 GFP-positive cells in each group from three independent experiments. **p < 0.01 versus Scr Insulin (1 nM) group.
(C) Endogenous GLUT4 accumulation in the TIRF zone in fixed adipocytes treated with or without insulin for 20 min. GLUT4 was detected with a goat anti-GLUT4
Ab and Alexa Fluor 488-conjugated donkey anti-goat Ab in permeabilized cells. Top andmiddle panels show 100 nm TIRF zone and representative GLUT4 TIRFM
images, respectively. Data are mean ± SD of three independent experiments with 300 plus cells in each group. **p < 0.01 versus Scr Insulin groups. Scale bars:
5 mm. See also Figure S2.
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reduces insulin-stimulated accumulation of myc-GLUT4-GFP
on the cell surface before initiation of endocytosis, it does not
significantly affect myc-GLUT4 endocytosis (Figure S2), sug-
gesting that CDP138 is specifically involved in the regulation of
GLUT4 exocytosis.
CDP138 Is Not Required for Endogenous GLUT4
Accumulation at the Periphery of the Adipocytes
We also quantified endogenous GLUT4 redistribution to the PM
using total internal reflection fluorescence microscopy (TIRFM)(C) Constitutively active Akt2 (myr-HA-Akt2) directly phosphorylates HA-CDP138 i
the phosphorylation target of myr-HA-Akt2 with MS (middle panel) as described
(Millipore) induces HA-CDP138-WT, but not HA-CDP-S197A, phosphorylation d
(D) CDP138 protein expression in mouse tissues. Tissue protein extracts (25 mg)
from ob/ob and lean male mice (24 weeks old, Jackson Laboratory) (middle pane
fat tissues from lean and obese mice (right panel). Data are mean ± SEM, **p < 0.
(A)–(C) are representatives of two to three independent experiments. See also Fi
Cell Mewith a setting of about 100 nm distance from the coverslip
(Figure 2C, top panel). For this experiment, endogenous
GLUT4 was detected by immunofluorescent staining with a
goat anti-GLUT4 Ab that recognizes the cytoplasmic C terminus
of GLUT4. The fluorescent signal therefore reflects the presence
of GLUT4 in the TIRF zone, either inserted in the PM and/or GSV
docked at or free near the PM. Figure 2C shows the TIRFM
images and quantification of GLUT4 distribution in the TIRF
zone. In 3T3-L1 adipocytes transfected with scrambled siRNA,
100 nM insulin enhanced the GLUT4 signal in the TIRF zone
by about 2.5-fold. Cells transfected with Akt2 siRNA showedn vitro kinase assays (left panel) and identification of S197 residue in CDP138 as
in Supplemental Experimental Procedures. Purified constitutively active Akt2
etected with PAS antibodies (right panel).
from different tissues of lean C57BL/6J mice (left panel) or epididymal fat pads
l) were analyzed by immunoblotting. Quantification of CDP138 protein levels in
01 lean versus ob/ob mice (n = 4). WAT or BAT: white or brown adipose tissue.
gure S1 and Table S1.
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Figure 3. Knockdown of CDP138 in Live 3T3-L1 Adipocytes Inhibits
Insulin-Stimulated Membrane Fusion between GLUT4 Storage Vesi-
cles and the PM, but not GLUT4-EGFP Trafficking to the TIRF Zone
(A) Schematic illustration of the molecular probes and TIRF microcopy-based
live cell assays for GLUT4 trafficking and GSV-PM fusion.
(B and C) The effect of CDP138 knockdown on insulin-stimulated IRAP-
pHluorin insertion into the PM (B) and accumulation of GLUT4-EGFP in the
TIRF zone (C). Adipocytes (day four) were transfected by electroporation with
plasmid DNA encoding IRAP-pHluorin or GLUT4-EGFP, together with either
the scrambled siRNA or SMARTpool siRNA against mouse 5730419I09Rik.
Cells were reseeded for 72 hr, serum-starved for 2 hr, then stimulated with
100 nM insulin for 30 min. Analyses were performed in a cell warmer adapted
for a Nikon TiE with fully motorized combined dual laser (488 and 561nm).
Images were acquired every 3 min immediately after addition of insulin and
analyzed as described in the Supplemental Experimental Procedures.
Perfect focus system and multiple points capture program were used to
acquire images from multiple positively transfected cells at each time point.
Data are mean ± SEM of three independent experiments (n = 3), with a total
of 159 cells (43, 46, 70/experiment, Scr siRNA) or 154 cells (43, 37, 74/
experiment, CDP138 siRNA) in the GLUT4-EGFP trafficking assay and a
total of 125 cells (41, 48, 36/experiments, Scr siRNA) or 120 cells (43, 46, 31/
experiments, CDP138 siRNA) in the GSV-PM fusion assay. p value: CDP138
siRNAs versus scrambled siRNA. Live cell movies for IRAP-pHluorin
membrane fusion assay are provided in Movies S1 and S2. See also
Figure S3.
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to the periphery, consistent with the concept that Akt2 plays a
role in GLUT4 trafficking. In contrast, knockdown of CDP138
did not inhibit insulin-stimulated GLUT4 accumulation at the
periphery (Figure 2C). This finding appears inconsistent with
the results obtained with the myc-GLUT4-GFP translocation
assay that showed reduction of GLUT4 on the cell surface by
silencing CDP138 (Figure 2B). However, both observations are
consistent with the possibility that CDP138 is specifically
required for the insertion of GLUT4 into the PM, but not for
GSV movement to the periphery, whereas Akt2 is known to be
involved in both steps.
CDP138 Is a Key Factor Involved in the Process
of Fusion between GSV and the PM
To determine whether CDP138 is required for insulin-stimulated
fusion between GLUT4 vesicles and the PM, we used a TIRFM-
based live cell fusion assay (Jiang et al., 2008). The assay is
based on the expression of a fusion protein of insulin-respon-
sive aminopeptidase (IRAP) tagged with the pH-sensitive green
fluorescence protein pHluorin at its lumenal terminus. The resul-
tant molecular probe (IRAP-pHluorin) colocalizes with the
insulin-responsive GSV in 3T3-L1 adipocytes. IRAP-pHluorin
is essentially nonfluorescent at pH 6.0 within the GSV, but is
very brightly fluorescent at the pH 7.4 environment that is
created when GSV has fused with the PM, as illustrated in Fig-
ure 3A (Jiang et al., 2008; Lopez et al., 2009). Therefore, this
molecular probe provides a sensitive tool to monitor dynamic
changes in GSV-PM fusion, with the pHluorin fluorescence
intensity reflecting the fusion event. As reported by Lopez
et al. (2009), the Akt1/2 inhibitor Akti partially but significantly in-
hibited both insulin-induced membrane fusion in live adipocytes
and myc-GLUT4-GFP translocation to cell surface in fixed cells
(Figure S3). In comparison to scrambled siRNA-treated cells,
knockdown of CDP138 significantly diminished the pHluorin
intensity within a 30 min period of insulin treatment (Figure 3B
and Movies S1 and S2). Quantitatively, silencing of CDP138
inhibited the insulin-induced IRAP-pHluorin signal by about
35% (Figure 3B). This partially inhibitory effect could be due
to incomplete knockdown of CDP138 and the presence of other
factors or pathways that are also required for GLUT4-PM fusion
(Lopez et al., 2009). However, knockdown of CDP138 did not
significantly affect insulin-stimulated GLUT4-EGFP accumula-
tion in the TIRF zone in live adipocytes (Figure 3C). Taken
together, our data suggests that CDP138 is specifically required
for insulin-stimulated GSV fusion with the PM, but not for
the movement of the vesicles from intracellular stores to the
TIRF zone.
The C2 Domain of CDP138 Has Two Ca2+-Binding Sites
that Are Critical for Membrane Lipid Binding
The primary amino acid sequence of the CDP138 C2 domain is
similar to the C2A and C2B domains from synaptotagamin-1,
with five conserved aspartate residues in loop 1 and loop 3
regions (Figure 4A) thatmay interact with Ca2+. To test this possi-
bility, we performed biophysical and functional analyses on the
isolated C2 domain fused to maltose-binding protein (MBP).
MBP, MBP-C2-WT, and MBP-C2-5DA, a mutant lacking five
aspartate residues (Figure 4B), have been analyzed for theirr Inc.
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Figure 4. The Purified C2 Domain from CDP138 Is Capable of Binding Ca2+ Ions and Lipid Membranes
(A) Diagram and amino acid alignment of the C2 domains of CDP138 (CDP138-C2) and synaptotagmin-1 (Sytg1-C2A and Sytg-C2B). b: beta strands; a: alpha
helix; loop: coil loop. The conserved potential Ca2+-binding aspartate residues are highlighted.
(B) Gel images of purified MBP (42kDa), MBP-C2-WT domain, and MBP-C2-5DA mutant.
(C) Calcium binds to thewild-typeC2 domain but not to the 5DA or theMBP proteins. Change in tryptophan fluorescence intensity at 340 nm as a signal of calcium
interaction with the MBP-C2-WT fusion protein, MBP-C2-5DA mutant fusion protein, and MBP measured at 37C. The calcium-binding isotherm was con-
structed as described in Supplemental Experimental Procedures. Calcium exerts a biphasic effect on tryptophan fluorescence of the wild-type protein, but has
little effect on the 5DA or MBP proteins. The curve of calcium binding to MBP-C2-WT was constructed using two independent binding sites per wild-type C2
domain, with dissociation constants of KD,1 = 0.03 ± 0.012 mM and KD,2 = 15.0 ± 6 mM.
(D) Fluorescence resonance energy transfer (RET) from protein tryptophan residues to Py-PE in membrane indicates membrane binding by the MBP-C2 WT
fusion protein, but not by the MBP-5DA-C2 mutant or MBP proteins. Change in tryptophan fluorescence intensity as a function of lipid concentration, corrected
for the effect of membranes without energy acceptor Py-PE, measured at 37C. The solid line describingmembrane binding of MBP-C2-WTwas simulated using
a lipid-to-protein stoichiometry N = 20 and a dissociation constantKD = 0.06 ± 0.015 mM. All data is presented asmean ± SD from three independent experiments.
See also Figure S4.
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C2-5DA domain fusion protein migrates faster in SDS-PAGE
than the wild-type fusion protein, because the substitution of
five aspartate residues with alanine changes the molecular
weight and charge of the protein.
Ca2+-Binding Property of the C2 Domain
Calcium binding to the fusion proteins was directly measured by
assessing Ca2+-induced changes in tryptophan fluorescence
(Figure S4A). The data in Figure 4C show that increasing Ca2+
concentrations exert a biphasic effect on the fluorescence of
the wild-type protein; fluorescence intensity increases at Ca2+
concentrations up to 2–3 mM and then decreases at higher
Ca2+ concentrations. Analysis of the biphasic effect indicated
that the wild-type protein has both a high affinity (KD =
0.03 mM) and a lower affinity (KD = 15.0 mM) Ca
2+-binding site.Cell MeThe effect of Ca2+ ions on the fluorescence of the 5DA mutant
protein and on MBP was negligible (Figure 4C).
Binding of C2 Domain to Lipid Membranes
Protein-lipid membrane interactions were studied by resonance
energy transfer (RET), as described earlier (Qin et al., 2004). The
fusion proteins were incubated with lipid vesicles containing 2%
Py-phosphatidylethanolamine (Py-PE), and tryptophans were
excited at 290 nm. If the protein binds to the membrane, the
energy of the excited electrons of tryptophan’s indole ring can
be transferred to the pyrene group of Py-PE. The data shown
in Figure 4D demonstrate clearly that the RET effect is only
observed with the wild-type C2 domain, but not the 5DA mutant
or MBP proteins. The spectra sets collected when the proteins
were titrated are presented in Figure S4B. These data were
used to determine lipid binding-dependent change in tryptophantabolism 14, 378–389, September 7, 2011 ª2011 Elsevier Inc. 383
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Figure 5. CDP138 Colocalizes with Phospho-Akt and Is Required for
Constitutively Active myr-Akt2-Induced GLUT4 Translocation
(A and B) HA-CDP138-WT was transfected into adipocytes (A) and CHO-T
cells (B) for 48 hr before serum starvation overnight. Cells were then treated
with or without insulin (100 nM) for 10 min. Cells were fixed and permeabilized
before immunostaining with mouse anti-HA and rabbit anti-phospho-Akt
(S473) antibodies followed by goat anti-mouse (Alexa Fluor 568) and goat anti-
rabbit (Alexa Fluor 488) secondary antibodies, respectively. The white arrow
indicates colocalization of phospho-Akt and HA-CDP138. Scale bar: 10 mm.
(C) Differentiated adipocytes were transfected by electroporation with the
scrambled siRNA or CDP138 siRNAs together with plasmid DNAs encoding
myc-GLUT4-GFP and myr-HA-Akt2 or HA-empty vector. Cells were reseeded
for 60 hr before serum starvation overnight. myc-GLUT4 translocation assays
were carried out with TIRF microscopy as described in the Experimental
Procedures. Data aremean ± SEMof four independent experiments. **p < 0.01
myr-Akt2 / CDP138 siRNA versus myr-Akt2 / Scr siRNA.
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Akt Substrate CDP138 Regulates GLUT4-PM Fusionfluorescence intensity at 340 nm, DF340. For the wild-type C2
domain, the data predict lipid-to-protein stoichiometry of N =
20 and a dissociation constant of KD = 0.06 mM. Data for the
5DA and MBP proteins did not indicate membrane binding.
CDP138 Is Partially Colocalized with Active Akt and
Facilitates Constitutively Active Akt2-Induced GLUT4
Translocation
To examine if CDP138 colocalizes with Akt, adipocytes and
CHO-T cells were transfected with HA-CDP138 expression384 Cell Metabolism 14, 378–389, September 7, 2011 ª2011 Elsevievector. We consistently observed insulin-stimulated HA-
CDP138 colocalization with active Akt, detected with phospho-
S473 Akt-specific Ab, at the PM cortical area in adipocytes
and at the membrane ruffles in CHO-T cells (Figures 5A and 5B).
It is established that constitutively active Akt induces GLUT4
translocation independent of insulin stimulation. To determine
if CDP138 functions downstream of Akt2, differentiated adipo-
cytes were transfected with active myr-HA-Akt2 and myc-
GLUT4-GFP, together with either the scrambled siRNA or siRNA
against mouse CDP138. TIRFM was then used to quantify the
effect of active myr-HA-Akt2 on the translocation of myc-
GLUT4-GFP to the cell surface. As shown in Figure 5C, overex-
pression of active Akt2 stimulated GLUT4 translocation about
2.5-fold in adipocytes transfected with the scrambled siRNA.
However, siRNA-induced knockdown of CDP138 significantly
inhibited the effect of constitutively active Akt2 on GLUT4 trans-
location. As noted above, knockdown of CDP138 did not alter
insulin-stimulated Akt phosphorylation (Figure 2A). Together,
these data confirm that CDP138 functions downstream of the
Akt2 pathway and is required for maximal Akt2-induced GLUT4
translocation.
The C2 Domain and Akt Phosphorylation Site Are Both
Required for the Normal Function of CDP138 in GLUT4
Translocation
We next determined if the C2 domain and Akt2 phosphorylation
site in CDP138 are necessary for GLUT4 translocation. myc-
GLUT4-GFP translocation was tested in the presence of the
HA-CDP138-WT or mutant proteins that lack (a) the C2 domain
(DC2 AA1-108), (b) the Ca2+-binding aspartate residues (5DA),
or (c) the Akt2 phosphorylation site S197 (S197A). Insulin-stimu-
lated myc-GLUT4-GFP translocation was quantified as the ratio
of cell surface myc signal (detected with TIRFM) to the total GFP
signal in the widefield image (Epi-GFP). As shown in Figures 6A
and 6B, overexpression of HA-CDP138-WT did not significantly
alter GLUT4 translocation. However, overexpression of all
three constructs (HA-CDP138-DC2, HA-CDP138-5DA, and
HA-CDP138-S197A) inhibited the insulin-stimulated transloca-
tion of myc-GLUT4-GFP to the cell surface, with the DC2
construct being the most inhibitory. Our phosphopeptide
analysis showed that CDP138 is also phosphorylated at the
S200 residue. Thus, we compared the effects of overexpressed
mutants lacking either S197 or S200 on insulin-stimulated myc-
GLUT4-GFP translocation. Interestingly, only S197A, but not
S200A, blocked GLUT4 translocation (Figure S5), further sug-
gesting that Akt2-dependent phosphorylation of S197 is neces-
sary for CDP138 function, but phosphorylation of S200 is not.
We have constructed similar mutants of CDP138 as described
above, but with mCherry fused at their C terminus, and com-
pared their effect on insulin-stimulated GLUT4 trafficking and
GSV-PM fusion, as detected with TIRFM in live adipocytes using
GLUT4-EGFP and IRAP-pHluorin as the molecular probes,
respectively. Our data show that the CDP138-5DA-mCherry
and CDP138-S197A-mCherry mutants inhibited membrane
fusion, but the CDP138-WT-mCherry or mCherry control vector
had no effect (Figure 6C). Despite their effect on membrane
fusion, none of the constructs significantly affected the insulin-
stimulated accumulation of GLUT4-EGFP in the TIRF zone (Fig-
ure 6D). These data suggest that Akt2-induced phosphorylationr Inc.
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Figure 6. The Effects of CDP138-DC2, CDP138-5DA, and CDP138-S197A Mutants on myc-GLUT4-GFP Translocation and GSV-PM Fusion
in 3T3-L1 Adipocytes
(A–E) Plasmid DNAs for pCMV5-HA, HA-CDP138-WT, HA-CDP138-DC2, HA-CDP138-5DA, or HA-CDP138-S197A were transfected by electroporation into
adipocytes together with the myc-GLUT4-GFP expression vector. Cells were reseeded for 48 hr and serum-starved overnight. Cells were then treated with or
without insulin (100 nM) for 30 min, before being immunostained with rabbit anti-myc and mouse anti-HA antibodies. Schematic diagram for CDP138 (wild-type
and mutants) and representative images of the myc-GLUT4-GFP translocation assay using TIRF microscopy; scale bars: 5 mm (A). GLUT4 translocation to the
cell surface of fixed adipocytes is shown as the ratio of surface TIRF myc signal to total Epi GFP (B). Data are presented as mean ± SEM of three independent
experiments. **p < 0.01 (n = 3);DC2, 5DA, or S197A versus HA vector. The effects of CDP138-mCherry constructs on insulin-inducedGSV-PM fusion andGLUT4-
EGFP trafficking in live adipocytes, respectively (C and D). Data are expressed in arbitrary units as the ratio of pHluorin or EGFP intensity to the basal intensity at
time zero. Data are mean ± SEM of three independent experiments (total 65–137 cells each group). p value (n = 3): S197A or 5DA versus mCherry vector.
Overexpression of humanWT but not mutant CDP138-mCherry rescues siRNA-induced inhibition of GSV-PM fusion in live adipocytes (E). Adipocytes (day four)
were transfected with the scrambled siRNA or smartPool siRNA against mouse 5730419I09Rik together with plasmid DNAs encoding IRAP-pHluorin
and mCherry alone, CDP138-WT-mCherry, CDP138-S197A-mCherry, or CDP138-5DA-mCherry for 72 hr before GSV-PM fusion assay. Error bars represent
mean ± SEM of three independent experiments (total 137–153 cells each group). p value (n = 3): * and ** CDP138 siRNA plus S197A or 5DA versus Scr siRNA plus
mCherry vector. #p < 0.05 or ##p < 0.01: CDP138 siRNA plus mCherry vector versus Scr siRNA plus mCherry vector. See also Figure S5.
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Akt Substrate CDP138 Regulates GLUT4-PM Fusionand Ca2+-binding by CDP138 are both important for GSV-PM
fusion, but not GSV trafficking in adipocytes.
To evaluate the rescue effects of CDP138-mCherry on
CDP138 siRNA-induced inhibition of GSV-PM fusion, mouse
CDP138 siRNAs were cotransfected into 3T3-L1 adipocytes,
together with IRAP-pHluorin and siRNA-resistant human
CDP138-mCherry (WT ormutants). Figure 6E shows that overex-
pressed human WT CDP138-mCherry reverses the CDP138
siRNA-induced inhibitory effect on the membrane fusion, while
overexpressed S197A or 5DA mutant further enhances the inhi-
bition, suggesting the effect of CDP138 on GSV-PM fusion is
gene specific.
CDP138 Is Dynamically Associated with the PM
and GLUT4 Vesicles
To examine the intracellular distribution of CDP138, we coex-
pressed myc-GLUT4-GFP and HA-CDP138 in adipocytes. As
shown in Figure 7A, in the basal state intracellular staining of
HA-CDP138-WT was punctuate and only partially overlapped
with GLUT4 vesicles in intracellular stores. Within 10 min of
insulin stimulation, GLUT4 and CDP138 can be seen colocalized
at the PM. A similar pattern was observed in stable CHO-T cell
lines expressing myc-GLUT4-GFP (Figure 7A). Next, we used
self-generated OptiPrep iodixanol gradient fractionation (Chen
et al., 2007) to examine the subcellular distribution of CDP138
and GLUT4 in adipocytes (see Figure S6A for method character-
ization). CDP138 was partially redistributed from high density
fractions to the lower density portion of the PM fractions within
10 min of insulin stimulation (Figures 7B and S6B). After
30 min, CDP138 had partially redistributed within PM fractions.
We analyzed CDP138 distribution in GLUT4 vesicles enriched
with conjugated monoclonal anti-GLUT4 Ab (1F8). Interestingly,
we also detected a small increase of CDP138 with enriched
GLUT4 vesicles within 10 min (Figure 7C). However, this associ-
ation was undetectable 30 min after stimulation, when total
GLUT4 content in the enriched vesicles was also reduced by
about 35% (Figure 7C). These data suggest that CDP138
dynamically interacts with the PM and GLUT4 vesicles.
DISCUSSION
It is known that activation of Akt2 is required for insulin-stimu-
latedGLUT4 translocation and that Akt2 acts by regulatingmobi-
lization of GSV and fusion between GSV and the PM (Zaid et al.,
2008). It has been reported previously that Akt2 controls GLUT4
retention and trafficking by phosphorylating the RabGAP AS160.
However, the molecular mechanism by which Akt2 regulates
GLUT4 insertion into the PM, a rate-limiting step of GLUT4
translocation, remains unclear. In the present study, we used
a SILAC quantitative phosphoproteomic approach to identify
the previously unknown CDP138, and confirmed that it is an
Akt2 substrate. RNAi-based functional assays revealed that
CDP138 is required for maximal insulin-stimulated glucose
transport and GLUT4 translocation to the PM, but not for
GLUT4 movement to the periphery in adipocytes. We used
both pH-sensitive IRAP-pHluorin and GLUT4-EGFP as molec-
ular probes to demonstrate in live adipocytes that CDP138 is
critical for optimal membrane fusion between GSV and the PM,
but not for GSV trafficking to the TIRF zone. Collectively, these386 Cell Metabolism 14, 378–389, September 7, 2011 ª2011 Elseviecomplementary functional analyses demonstrate that the
phosphoprotein CDP138 is involved in regulatingGLUT4 translo-
cation, most likely at the GSV-PM fusion step. Thus, CDP138
represents a link between Akt2 activation and GLUT4 insertion
into the PM. It is possible that Akt2 regulates the GLUT4
trafficking and membrane fusion steps in adipocytes through
the RabGAP AS160 and CDP138, respectively (Figure 7D).
Our results are consistent with the hypothesis that CDP138
is a downstream target of Akt2 and is involved in the regulation
of GLUT4 translocation. First, insulin stimulated phosphorylation
of CDP138 in cultured cells, and the phosphorylation was
partially blocked by the PI3K inhibitors. We also detected several
phosphorylation sites in CDP138 by MS, which suggests that
insulin might induce CDP138 phosphorylation at different sites
through both PI3K-dependent and -independent pathways.
Second, we showed that constitutively active Akt2 induced
CDP138 phosphorylation at a S197 residue within a consensus
Akt substrate motif. Overexpression of a mutant CDP138 lacking
the S197 phosphorylation site, but not S200, significantly
inhibited insulin-stimulated myc-GLUT4-GFP translocation to
the cell surface and GSV-PM fusion in adipocytes, suggesting
that S197 phosphorylation is important to the glucose trans-
porter system. Third, overexpressed human WT, but not
S197A or 5DA mutant CDP138, rescues the mouse CDP138
siRNA-induced inhibitory effect on the membrane fusion in
3T3-L1 adipocytes. Fourth, our results showed that CDP138 co-
localizes with phospho-Akt in insulin-stimulated cells. We also
observed that CDP138 interacts with Akt2 upstream kinase
PDK1 in a proteomics study, and this was confirmed in a coim-
munoprecipitation study (data not shown). These observations
suggest the interesting possibility that the CDP138-PDK1 inter-
action might bring CDP138 and phospho-Akt2 into close prox-
imity at the PM. This might be mediated through PI3K-derived
PI(3,4,5)P3, which interacts with the PH domains of both PDK1
and Akt2 in insulin-stimulated cells. If this occurs, CDP138would
become accessible to phosphorylation by active Akt2. Further-
more, RNAi-induced gene specific knockdown of CDP138 did
not affect insulin-stimulated Akt phosphorylation, but signifi-
cantly inhibited GLUT4 translocation induced by constitutively
active Akt2, suggesting this phosphoprotein functions down-
stream of the Akt2 pathway.
To understand the molecular mechanism by which CDP138
regulates GLUT4 translocation, we also analyzed the biochem-
ical and functional interactions of the C2 domain-containing
protein. Deletion of the C2 domain from CDP138 significantly
inhibited insulin-stimulated GLUT4 translocation, suggesting
the C2 domain is crucial for this process. The C2 domain of
CDP138 is similar to those of known membrane-fusion proteins
such as synaptotagmin. Biophysical analyses revealed that the
purified C2 domain of CDP138 is able to bind Ca2+ and lipo-
somes with a lipid composition that mimics the cytoplasmic
face of plasma membranes. It is interesting to note that the C2
domain contains two Ca2+-binding sites of differing affinity,
presumably one each in loop 1 and 3. The mutant C2 domain
lacking five aspartate residues in loop1 and 3 regions is unable
to bind Ca2+ or membrane lipids, suggesting that interaction of
the C2 domain with lipids is Ca2+-dependent. It is possible that
Ca2+-binding to the C2 domain results in exposure of nonpolar
residues that mediate membrane binding. Alternatively, Ca2+r Inc.
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Figure 7. CDP138 is Colocalized with GLUT4 at the PM and Dynamically Associated with the PM Fractions and GLUT4 Vesicles
(A) HA-CDP138-WT plasmid DNA was transfected alone into a CHO-T cell line stably expressing myc-GLUT4-GFP or into adipocytes together with the
myc-GLUT4-GFP vector. Serum-starved cells were treated with or without insulin 48 hr later, for 10 min, before immunofluorescent staining with anti-HA Ab,
as described for Figure 5. Scale bars: 10 mm. Images are representative of three independent experiments.
(B) Postnuclear supernatants from 3T3-L1 adipocytes, treated with or without insulin (100 nM), were fractionated with iodixanol gradients (10%, 20%, and 30%)
(OptiPrep) as described in Supplemental Experimental Procedures. Equal volumes of each fraction were resolved in 4%–20% SDS-PAGE followed by immu-
noblotting with antibodies against CDP138, p-Akt, and GLUT4. For quantification, the results were normalized to the total level of the indicated protein. Images
are representative of and data are mean ± SEM of three independent experiments.
(C) GLUT4 vesicles were enriched by immunoabsorption with anti-GLUT4 Ab (1F8) from adipocytes after removal of nuclear fraction as described in Supple-
mental Experimental Procedures. Samples were then immunoblotted with anti-CDP138 and anti-GLUT4 antibodies. Images are representative of three inde-
pendent experiments.
(D) Akt substrate CDP138 is a potential link between Akt2 activation and GSV-PM fusion. See also Figure S6.
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Akt Substrate CDP138 Regulates GLUT4-PM Fusionions may serve as ionic bridges between acidic residues of
the protein and negatively charged membranes. Interestingly,
in the studies using GLUT4 vesicles and density gradient frac-
tionation of membrane compartments, we also observed that
CDP138 associated with GLUT4 vesicles and the lower density
PM-containing fractions within 10min of treatment of adipocytes
with insulin. Surprisingly, CDP138 dissociated from the vesicles
and redistributed in the PM-containing fractions in adipocytes
after 30 min. These dynamic interactions further support the
notion that CDP138 may be involved in the regulation of
GLUT4 vesicle fusion with the PM, either directly or indirectly.
Since CDP138 is a highly regulated phosphoprotein, it is unique
among proteins known to be involved in membrane fusion
processes. Further studies are needed to understand the molec-
ular basis by which CDP138 regulates membrane fusion.
EXPERIMENTAL PROCEDURES
DNA Constructs, siRNAs, and Antibodies
Constitutively active HA-myr-Akt2 in the pcDNA3 expression vector was from
Addgene (Cambridge, MA). IRAP-pHluorin and GLUT4-EGFP were kindly
provided by Dr. Tao Xu (Institute of Biophysics, Beijing, China). The pCMV5
plasmid DNA encoding myc-GLUT4-GFP was constructed as described
(Jiang et al., 2002). The cDNA clone of human kiaa0528 was used to make
a full-length CDP138 taggedwith an HA epitope at the N terminus andmCherry
at the C terminus as described in Supplemental Experimental Procedures. The
mutants of HA-CDP138 and CDP138-mCherry, including DC2, 5DA, S197A,
and S200A were made by PCR-based mutation. SiRNA duplexes against
mouse 5730419I09RIK and Akt2 are described in Supplemental Experimental
Procedures. Abs used for immunoprecipitation and immunoblotting are
described earlier (Zhou et al., 2010) and in Supplemental Experimental
Procedures.
Cell Culture, siRNA, and Gene Transfection, and SILAC Medium
3T3-L1 adipocytes were transfected with siRNA duplexes or DNA constructs
by electroporation as described (Jiang et al., 2003). Oligofectamine Reagent
(Invitrogen) was used for transfection of plasmid DNA into CHO-T and
HEK293 cells. DMEM containing Arg-0/Lys-H4, Arg-6/Lys-D4, and Arg-10/
Lys-8 were used for SILAC experiments.
Mass Spectrometric Analysis
After SDS-PAGE, in-gel trypsin digestion, and peptide extraction, samples
were processed for LC-MS as described in Supplemental Experimental
Procedures.
CDP138 C2 Domain Purification, Calcium and Lipid
Membrane-Binding Assays
MBP- WT1–118 and MBP-5DA1–118 in pMal-C2 vector (Amersham) were
expressed in BL21 bacteria and purified as described in Supplemental Exper-
imental Procedures. Binding of C2 domain fusion proteins to lipid membranes
and Ca2+ were determined by fluorescence resonance energy transfer as
described earlier (Qin et al., 2004) and by tryptophan fluorescence spectra
as described in Supplemental Experimental Procedures, respectively.
Deoxyglucose Uptake Assay
To detect the effect of gene silencing on insulin-stimulated glucose transport,
[3H]-deoxyglucose uptake assays were carried out in 3T3-L1 adipocytes, as
described earlier (Jiang et al., 2003) and in Supplemental Experimental
Procedures.
In Vitro Protein Kinase Assay
For the in vitro Akt2 kinase assays, either purified constitutively active His6-
Akt2 (DPH, S474D, and PDK1 activated) or overexpressed HA-tagged myr-
Akt2 was used for inducing HA-CDP138 phosphorylation, as described in
Supplemental Experimental Procedures.388 Cell Metabolism 14, 378–389, September 7, 2011 ª2011 ElsevieIsolation of GLUT4-Containing Vesicles and Subcellular
Fractionation
Serum-starved 3T3-L1 adipocytes were stimulated with or without 100 nM
insulin for 10 min or 30 min. GLUT4 vesicles were enriched by immunoadsorp-
tion with anti-GLUT4 Ab (1F8) from adipocytes after removal of nuclear and the
PM fractions, as previously described (Kandror and Pilch, 2006). Postnuclear
subcellular fractionation was performed by ultracentrifugation with continuous
iodixanol gradients, as described earlier (Chen et al., 2007) and in Supple-
mental Experimental Procedures.
GLUT4 Translocation Detection with Widefield Fluorescence
and TIRF Microscopy
Both widefield and TIRF microscopy were used to detect myc-GLUT4-GFP
translocation to the cell surface, as previously described (Jiang et al., 2002)
and in Supplemental Experimental Procedures.
Analysis of GLUT4 Trafficking and GSV-PM Fusion in Live Cells
with TIRF Microscopy
Differentiated adipocyteswere transfected by electroporationwith the plasmid
DNA encoding IRAP-pHluorin or GLUT4-EGFP and siRNAs, or pcDNA3-
mCherry constructs encoding CDP138 fusion protein and its mutants. Live
cell imaging was performed to measure membrane fusion and GLUT4
trafficking with IRAP-pHluorin andGLUT4-EGFP asmolecular probes, respec-
tively, as described in Supplemental Experimental Procedures.
Statistics
For all the quantified data, population averages are given as mean and stan-
dard deviation (SD) or standard error of the mean (SEM). Statistical signifi-
cance was tested using unpaired two-tailed Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.cmet.2011.06.015.
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